{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:21:07Z","timestamp":1778055667662,"version":"3.51.4"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","funder":[{"name":"the Natural Science Foundation of Guangdong Province","award":["2025A1515011778"],"award-info":[{"award-number":["2025A1515011778"]}]},{"name":"Zhujiang Hospital of Southern Medical University","award":["yzjj2022qn32"],"award-info":[{"award-number":["yzjj2022qn32"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      Current evidence regarding radiomics-based assessment of persistent\/recurrent cervical lymph node metastasis (CLNM) remains limited, particularly in the field of PET\/CT in papillary thyroid cancer (PTC). Therefore, we aimed to construct a prediction model for persistent\/recurrent CLNM of PTC by fluoro-18-deoxyglucose (\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG) PET\/computed tomography (CT) multimodal radiomics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We retrospectively analyzed postoperative patients with PTC who underwent\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT at our hospital between June 2021 and June 2024. A total of 425 CLNs (219 metastatic and 206 nonmetastatic) from 158 patients were included, and the patients were randomly assigned to a training set and a test set at a ratio of 7\u2005:\u20053. Pearson correlation analysis and least absolute shrinkage and selection operator regression were utilized to select PET\/CT radiomic features for model development. Five radiomics models were developed based on distinct feature sets: clinical features alone, CT radiomics, PET radiomics, PET\/CT radiomics, and integrated PET\/CT radiomics combined with clinical features. Subsequently, a nomogram model was built by combining radscore and clinical features.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The integrated model demonstrated superior diagnostic accuracy, with areas under the curve (AUCs) of 0.944 in the training set and 0.922 in the test set. PET\/CT models demonstrated the following AUCs: PET\/CT (0.887), PET (0.834), CT (0.775), and clinical features alone (0.783). A nomogram incorporating clinical features and radscores was then developed, achieving C-indices of 0.937 in the training set and 0.895 in the test set.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The integration of PET\/CT radiomics and clinical features may provide a noninvasive tool for predicting persistent\/recurrent CLNM in postoperative PTC patients, with potential to support clinical decision\u2011making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mnm.0000000000002124","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:00:07Z","timestamp":1771488007000},"page":"656-665","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Predicting persistent\/recurrent cervical lymph node metastasis in papillary thyroid carcinoma with PET\/CT-based multimodal radiomics: an image-pathology matching study"],"prefix":"10.1097","volume":"47","author":[{"given":"Pan","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuang","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Zhujiang Hospital of Southern Medical University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuitian","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erhao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxing","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijuan","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"R1-20260506","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20260506","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","article-title":"The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020.","volume":"10","author":"Pizzato","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R3-20260506","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","article-title":"Thyroid cancer.","volume":"401","author":"Chen","year":"2023","journal-title":"Lancet"},{"key":"R4-20260506","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States, 1974-2013.","volume":"317","author":"Lim","year":"2017","journal-title":"JAMA"},{"key":"R5-20260506","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association Management Guidelines for adult patients with differentiated thyroid cancer.","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"key":"R6-20260506","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/thy.2007.0269","article-title":"Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography.","volume":"18","author":"Kim","year":"2008","journal-title":"Thyroid"},{"key":"R7-20260506","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1007\/s00330-012-2470-x","article-title":"Detection of neck recurrence in patients with differentiated thyroid cancer: comparison of ultrasound, contrast-enhanced CT and (18)F-FDG PET\/CT using surgical pathology as a reference standard: (ultrasound vs. CT vs. (18)F-FDG PET\/CT in recurrent thyroid cancer).","volume":"22","author":"Seo","year":"2012","journal-title":"Eur Radiol"},{"key":"R8-20260506","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1007\/s00259-020-04938-0","article-title":"Comparison of simultaneous (18)F-2-[18F] FDG PET\/MR and PET\/CT in the follow-up of patients with differentiated thyroid cancer.","volume":"47","author":"Klain","year":"2020","journal-title":"Eur J Nucl Med Mol I"},{"key":"R9-20260506","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.diii.2021.04.004","article-title":"PET\/CT in the management of differentiated thyroid cancer.","volume":"102","author":"Zampella","year":"2021","journal-title":"Diagn Interventional Imaging"},{"key":"R10-20260506","first-page":"127","article-title":"Artificial intelligence in cancer imaging: clinical challenges and applications.","volume":"69","author":"Bi","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R11-20260506","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics: the bridge between medical imaging and personalized medicine.","volume":"14","author":"Lambin","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"R12-20260506","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/MNM.0000000000001672","article-title":"Utility of pre-treatment 18 F-fluorodeoxyglucose PET radiomic analysis in assessing nodal involvement in cervical cancer.","volume":"44","author":"Chan","year":"2023","journal-title":"Nucl Med Commun"},{"key":"R13-20260506","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1038\/s41467-020-18497-3","article-title":"Lymph node metastasis prediction of papillary thyroid carcinoma based on transfer learning radiomics.","volume":"11","author":"Yu","year":"2020","journal-title":"Nat Commun"},{"key":"R14-20260506","doi-asserted-by":"crossref","first-page":"15828","DOI":"10.1038\/s41598-024-66304-6","article-title":"Development and validation of a clinical predictive model for high-volume lymph node metastasis of papillary thyroid carcinoma.","volume":"14","author":"Zhu","year":"2024","journal-title":"Sci Rep"},{"key":"R15-20260506","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s40644-023-00629-9","article-title":"Analysis of preoperative computed tomography radiomics and clinical factors for predicting postsurgical recurrence of papillary thyroid carcinoma.","volume":"23","author":"Xu","year":"2023","journal-title":"Cancer Imaging"},{"key":"R16-20260506","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1007\/s00330-020-06866-x","article-title":"Radiomics analysis of dual-energy CT-derived iodine maps for diagnosing metastatic cervical lymph nodes in patients with papillary thyroid cancer.","volume":"30","author":"Zhou","year":"2020","journal-title":"Eur Radiol"},{"key":"R17-20260506","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s00330-017-5015-5","article-title":"Metastatic and non-metastatic lymph nodes: quantification and different distribution of iodine uptake assessed by dual-energy CT.","volume":"28","author":"Rizzo","year":"2018","journal-title":"Eur Radiol"},{"key":"R18-20260506","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00259-024-06664-3","article-title":"More than meets the eye: 2-[(18)F]FDG PET-based radiomics predicts lymph node metastasis in colorectal cancer patients to enable precision medicine.","volume":"51","author":"Huang","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R19-20260506","first-page":"599876956","article-title":"Diagnosing postoperative lymph node metastasis in thyroid cancer with multimodal radiomics and clinical features.","volume":"10","author":"Fan","year":"2024","journal-title":"Digit Health"},{"key":"R20-20260506","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1002\/mp.17193","article-title":"Preoperative prediction of lymph node metastasis in colorectal cancer using (18)F-FDG PET\/CT peritumoral radiomics analysis.","volume":"51","author":"Wang","year":"2024","journal-title":"Med Phys"},{"key":"R21-20260506","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1002\/cam4.4288","article-title":"Lymph node metastases >5 and metastatic lymph node ratio >0.30 of differentiated thyroid cancer predict response to radioactive iodine.","volume":"10","author":"Yun","year":"2021","journal-title":"Cancer medicine"},{"key":"R22-20260506","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/cen.14834","article-title":"Clinical and ultrasonic risk factors for high-volume central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a retrospective study and meta-analysis.","volume":"98","author":"Wang","year":"2023","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R23-20260506","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1007\/s00405-022-07782-0","article-title":"Surgical treatment and prognosis values of extranodal extension to recurrent laryngeal nerve in papillary thyroid carcinoma.","volume":"280","author":"Abuduwaili","year":"2023","journal-title":"Eur Arch Otorhinolaryngo"},{"key":"R24-20260506","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/cen.13378","article-title":"Management and outcome of clinically evident neck recurrence in patients with papillary thyroid cancer.","volume":"87","author":"Wang","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R25-20260506","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF03343973","article-title":"Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.","volume":"25","author":"Lima","year":"2002","journal-title":"J Endocrinol Invest"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000002124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:00:58Z","timestamp":1778054458000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000002124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0000000000002124","relation":{},"ISSN":["0143-3636","1473-5628"],"issn-type":[{"value":"0143-3636","type":"print"},{"value":"1473-5628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]}}}